KRILL OIL (KRILL OIL/OMEGA-3/DHA/EPA/OMEGA-6/PHOSPHOLIPIDS/ASTAXANTHIN)
krill 1,000 mg-omega-3 170 mg-dha 50 mg-epa 80 mg-phosph-astax capsule
- Dosage information is not available
krill 1,000 mg-omega-3 230 mg-dha 60 mg-epa-phosphlip-astaxan capsule
- Dosage information is not available
krill 300 mg-omega 3 90 mg-dha 24 mg-epa 50 mg-phospho-astax capsule
- Dosage information is not available
krill 300 mg-omega-3 90 mg-dha 27 mg-epa 45 mg-phospho-astaxan capsule
- Dosage information is not available
krill 500 mg-omega 3 115 mg-dha 30 mg-epa 64 mg-phospho-astax capsule
- Dosage information is not available
krill 500 mg-omega-3 110 mg-dha 28 mg-epa 60 mg-phospho-astax capsule
- Dosage information is not available
krill 500 mg-omega-3 150 mg-dha 45 mg-epa 75 mg-phospho-astax capsule
- Dosage information is not available
krill 500 mg-omega-3 86 mg-dha 25 mg-epa 40 mg-phospho-astaxan capsule
- Dosage information is not available
(Omega 3 and 6) 1,000 mg-130 mg (40 mg-80 mg) capsule
- Dosage information is not available
(Omega 3 and 6) 1,500 mg-165 mg-67.5 mg capsule
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- None
KRILL OIL (KRILL OIL/OMEGA-3/DHA/EPA/OMEGA-6/PHOSPHOLIPIDS/ASTAXANTHIN)
- None
- None
More Frequent
Severe
Less Severe
- None
- Dysgeusia
- Dyspepsia
- Eructation
- Skin rash
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Hemorrhage
- Increased alanine transaminase
- Increased aspartate transaminase
Less Severe
- Abnormal hepatic function tests
- Constipation
- Pruritus of skin
- Urticaria
- Vomiting
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
None
General | Excretion Potential | Effect on Infant | Notes |
None |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None